Resultados de procura - Gauri Varadhachary

  • Mostrando 1 - 9 Resultados de 9
Limitar resultados
  1. 1
    Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018

    Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 por Jonathan M. Loree, Seerat Anand, Arvind Dasari, Joseph M. Unger, Anirudh Gothwal, Lee M. Ellis, Gauri Varadhachary, Scott Kopetz, Michael J. Overman, Kanwal Raghav

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants

    Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants por Milind Javle, Einat Shacham‐Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David R. Fogelman, Ben Boursi, Syeda Uruba, Ofer Margalit, Robert A. Wolff, Talia Golan

    Publicado 2021
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

    Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies por Milind Javle, Rachna T. Shroff, Henry Xiong, Gauri Varadhachary, David R. Fogelman, Shrikanth A.G. Reddy, Darren W. Davis, Yujian Zhang, Robert A. Wolff, James L. Abbruzzese

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy

    Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy por Ching-Wei D. Tzeng, Jason B. Fleming, Jeffrey E. Lee, Xuemei Wang, Peter W. T. Pisters, Jean‐Nicolas Vauthey, Gauri Varadhachary, Robert A. Wolff, Matthew H. G. Katz

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

    Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators por Matthew H. G. Katz, Jason B. Fleming, Priya Bhosale, Gauri Varadhachary, Jeffrey E. Lee, Robert A. Wolff, Huamin Wang, James L. Abbruzzese, Peter W. T. Pisters, Jean‐Nicolas Vauthey, Chusilp Charnsangavej, Eric P. Tamm, Christopher H. Crane, Aparna Balachandran

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

    Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer por Hop S. Tran Cao, Alpana Balachandran, Huamin Wang, Christina E. Bailey, Jeffrey E. Lee, Peter W. T. Pisters, Douglas B. Evans, Gauri Varadhachary, Christopher H. Crane, Thomas A. Aloia, Jean‐Nicolas Vauthey, Jason B. Fleming, Matthew H. G. Katz, Graciela M. Nogueras‐González

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

    Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma por Matthew H. G. Katz, Huamin Wang, Jason B. Fleming, Charlotte C. Sun, Rosa F. Hwang, Robert A. Wolff, Gauri Varadhachary, James L. Abbruzzese, Christopher H. Crane, Sunil Krishnan, Jean‐Nicolas Vauthey, Eddie K. Abdalla, Jeffrey E. Lee, Peter W. T. Pisters, Douglas B. Evans

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes

    Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes por F Anthony San Lucas, Kelvin Allenson, Vincent Bernard, J. Castillo, D.U. Kim, Katherine Elizabeth Sleigh Ellis, Erik A. Ehli, Gareth E. Davies, Jason L. Petersen, D. Li, Robert A. Wolff, Matthew H. G. Katz, Gauri Varadhachary, Ignacio I. Wistuba, Anirban Maitra, Héctor M. Álvarez

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer

    4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer por Donastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, Vincent Bernard, Li Zhao, Young Uk Kim, Mark W. Hurd, Naohiro Uraoka, Edwin R. Parra, Ya’an Kang, Christopher A. Bristow, Jaime Rodriguez‐Canales, Jason B. Fleming, Gauri Varadhachary, Milind Javle, Michael J. Overman, Hector A. Alvarez, Timothy P. Heffernan, Jianhua Zhang, Patrick Hwu, Anirban Maitra, Cara Haymaker, Chantale Bernatchez

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: